These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33244007)

  • 1. Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties.
    Veligeti R; Madhu RB; Anireddy J; Pasupuleti VR; Avula VKR; Ethiraj KS; Uppalanchi S; Kasturi S; Perumal Y; Anantaraju HS; Polkam N; Guda MR; Vallela S; Zyryanov GV
    Sci Rep; 2020 Nov; 10(1):20720. PubMed ID: 33244007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents.
    Murahari M; Kharkar PS; Lonikar N; Mayur YC
    Eur J Med Chem; 2017 Apr; 130():154-170. PubMed ID: 28246041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
    Murahari M; Prakash KV; Peters GJ; Mayur YC
    Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of chemosensitization effect of acridones in cancer cell lines: Combined pharmacophore modeling, 3D QSAR, and molecular dynamics studies.
    Gade DR; Makkapati A; Yarlagadda RB; Peters GJ; Sastry BS; Rajendra Prasad VVS
    Comput Biol Chem; 2018 Jun; 74():63-75. PubMed ID: 29547875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation and virtual screening of some acridone derivatives as potential anticancer agents.
    Oyedele AS; Bogan DN; Okoro CO
    Bioorg Med Chem; 2020 May; 28(9):115426. PubMed ID: 32201193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of novel acridone derivatives as antiproliferative agents.
    Chen JN; Wu XK; Lu CH; Li X
    Bioorg Med Chem; 2021 Jan; 29():115868. PubMed ID: 33191085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide releasing acridone carboxamide derivatives as reverters of doxorubicin resistance in MCF7/Dx cancer cells.
    Rajendra Prasad VV; Deepak Reddy G; Kathmann I; Amareswararao M; Peters GJ
    Bioorg Chem; 2016 Feb; 64():51-8. PubMed ID: 26657603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of quinazolinone tagged acridones as cytotoxic agents and their effects on EGFR tyrosine kinase.
    Babu YR; Bhagavanraju M; Reddy GD; Peters GJ; Prasad VV
    Arch Pharm (Weinheim); 2014 Sep; 347(9):624-34. PubMed ID: 24866341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies.
    Rajendra Prasad VV; Peters GJ; Lemos C; Kathmann I; Mayur YC
    Eur J Pharm Sci; 2011 Jul; 43(4):217-24. PubMed ID: 21565270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of acridone-2-carbohydrazide derivatives as p-AKT Ser
    Yadav TT; Kumar MS; Bajaj S; Yc M
    Future Med Chem; 2023 Apr; 15(8):699-716. PubMed ID: 37170843
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular design, synthesis and biological research of novel pyridyl acridones as potent DNA-binding and apoptosis-inducing agents.
    Zhang B; Chen K; Wang N; Gao C; Sun Q; Li L; Chen Y; Tan C; Liu H; Jiang Y
    Eur J Med Chem; 2015 Mar; 93():214-26. PubMed ID: 25686590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis.
    Cholewiński G; Dzierzbicka K; Kołodziejczyk AM
    Pharmacol Rep; 2011; 63(2):305-36. PubMed ID: 21602588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Biological Evaluation of Acridine/Acridone Analogs as Potential Anticancer Agents.
    Gensicka-Kowalewska M; Cichorek M; Ronowska A; Deptuła M; Klejbor I; Dzierzbicka K
    Med Chem; 2019; 15(7):729-737. PubMed ID: 30324889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone-1,2,4-oxadiazole-1,2,3-triazole Hybrids.
    Mohammadi-Khanaposhtani M; Mahdavi M; Saeedi M; Sabourian R; Safavi M; Khanavi M; Foroumadi A; Shafiee A; Akbarzadeh T
    Chem Biol Drug Des; 2015 Dec; 86(6):1425-32. PubMed ID: 26077890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
    Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
    Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and evaluation of new acridone derivatives for selective binding of oncogene c-myc promoter i-motifs in gene transcriptional regulation.
    Shu B; Cao J; Kuang G; Qiu J; Zhang M; Zhang Y; Wang M; Li X; Kang S; Ou TM; Tan JH; Huang ZS; Li D
    Chem Commun (Camb); 2018 Feb; 54(16):2036-2039. PubMed ID: 29411851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive review on acridone based derivatives as future anti-cancer agents and their structure activity relationships.
    Yadav TT; Murahari M; Peters GJ; Yc M
    Eur J Med Chem; 2022 Sep; 239():114527. PubMed ID: 35717872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses and evaluation of acridone derivatives as anticancer agents targeting Kras promoter i-motif structure.
    Wei Z; Lin X; Wang S; Zhang J; Ji D; Gong X; Huang ZS; Shu B; Li D
    Bioorg Chem; 2023 Jul; 136():106526. PubMed ID: 37058782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
    Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
    J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.